MDP Technicals trying to retest 3rd time support near 1.48 and upon successful bounce back, it can jump above 3.5 easily. Some thing can be sensed here. Eps positve. So hope positive. Take your own decision and study before any blind call
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.13 CAD
−288.62 K CAD
152.48 M CAD
22.18 M
About MEDEXUS PHARMACEUTICALS INC
Sector
CEO
Kenneth d’Entremont
Headquarters
Bolton
Website
Founded
2003
FIGI
BBG0029BPQX0
Medexus Pharmaceuticals, Inc. operates as a pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and treatment solutions focusing on therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. The firm products include IXINITY, Rasuvo, Metoject, Rupall, and Gleolan. The company was founded in 2003 and is headquartered in Bolton, Canada.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MDP is 2.45 CAD — it has increased by 15.02% in the past 24 hours. Watch MEDEXUS PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange MEDEXUS PHARMACEUTICALS INC stocks are traded under the ticker MDP.
MDP stock has risen by 21.89% compared to the previous week, the month change is a −2.39% fall, over the last year MEDEXUS PHARMACEUTICALS INC has showed a 59.09% increase.
We've gathered analysts' opinions on MEDEXUS PHARMACEUTICALS INC future price: according to them, MDP price has a max estimate of 8.32 CAD and a min estimate of 2.62 CAD. Watch MDP chart and read a more detailed MEDEXUS PHARMACEUTICALS INC stock forecast: see what analysts think of MEDEXUS PHARMACEUTICALS INC and suggest that you do with its stocks.
MDP stock is 17.79% volatile and has beta coefficient of 0.54. Track MEDEXUS PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is MEDEXUS PHARMACEUTICALS INC there?
Today MEDEXUS PHARMACEUTICALS INC has the market capitalization of 60.40 M, it has increased by 0.47% over the last week.
Yes, you can track MEDEXUS PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
MEDEXUS PHARMACEUTICALS INC is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
MEDEXUS PHARMACEUTICALS INC revenue for the last quarter amounts to 35.59 M CAD, despite the estimated figure of 35.54 M CAD. In the next quarter, revenue is expected to reach 36.29 M CAD.
MDP net income for the last quarter is 150.04 K CAD, while the quarter before that showed 2.68 M CAD of net income which accounts for −94.40% change. Track more MEDEXUS PHARMACEUTICALS INC financial stats to get the full picture.
No, MDP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 82.00 employees. See our rating of the largest employees — is MEDEXUS PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDEXUS PHARMACEUTICALS INC EBITDA is 24.98 M CAD, and current EBITDA margin is 16.45%. See more stats in MEDEXUS PHARMACEUTICALS INC financial statements.
Like other stocks, MDP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDEXUS PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDEXUS PHARMACEUTICALS INC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDEXUS PHARMACEUTICALS INC stock shows the buy signal. See more of MEDEXUS PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.